Twists and turns in the function of DNA damage signaling and repair proteins by post-translational modifications

DNA Repair

Volumn 6, Issue 5, 2007, Pages 561-577

  Déry, Ugo ^a   Masson, Jean Yves ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

DNA damage signaling; DNA repair; Double strand breaks; Phosphorylation; Post translational modifications

Indexed keywords

7 HYDROXYSTAUROSPORINE; ARGININE; ATM PROTEIN; DNA; HISTONE; HYDROXYUREA; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE C; RAD51 PROTEIN; UBIQUITIN;

CELL CYCLE; CHROMATIN STRUCTURE; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; ENZYME ACTIVATION; HUMAN; HUMAN GENOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DNA; DNA DAMAGE; DNA REPAIR; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; SIGNAL TRANSDUCTION;

EID: 34047114509     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2006.12.009     Document Type: Review

References (182)

1. Weinert T.A., and Hartwell L.H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241 (1988) 317-322
2. Bartkova J., Bakkenist C.J., Rajpert-De Meyts E., Skakkebaek N.E., Sehested M., Lukas J., Kastan M.B., and Bartek J. ATM activation in normal human tissues and testicular cancer. Cell Cycle 4 (2005) 838-845
3. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., Ditullio Jr. R.A., Kastrinakis N.G., Levy B., Kletsas D., Yoneta A., Herlyn M., Kittas C., and Halazonetis T.D. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
4. Savitsky K., Barshira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., and Sfez S. A single Ataxia telangiectasia gene with a product similar to Pi-3 kinase. Science 268 (1995) 1749-1753
5. Shiloh Y. Ataxia telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet. 31 (1997) 635-662
6. Abraham R.T. PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways. DNA Repair (Amst.) 3 (2004) 883-887
7. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15 (2001) 2177-2196
8. Painter R.B., and Young B.R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 7315-7317
9. Donaldson A.D., and Blow J.J. The regulation of replication origin activation. Curr. Opin. Genet. Dev. 9 (1999) 62-68
10. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
11. Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31 (2006) 402-410
12. Kozlov S.V., Graham M.E., Peng C., Chen P., Robinson P.J., and Lavin M.F. Involvement of novel autophosphorylation sites in ATM activation. EMBO J. 25 (2006) 3504-3514
13. Sun Y., Jiang X., Chen S., Fernandes N., and Price B.D. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13182-13187
14. Goodarzi A.A., Jonnalagadda J.C., Douglas P., Young D., Ye R., Moorhead G.B., Lees-Miller S.P., and Khanna K.K. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J. 23 (2004) 4451-4461
15. Ali A., Zhang J., Bao S., Liu I., Otterness D., Dean N.M., Abraham R.T., and Wang X.F. Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes Dev. 18 (2004) 249-254
16. Kitagawa R., Bakkenist C.J., McKinnon P.J., and Kastan M.B. Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev. 18 (2004) 1423-1438
17. Goldstine J.V., Nahas S., Gamo K., Gartler S.M., Hansen R.S., Roelfsema J.H., Gatti R.A., and Marahrens Y. Constitutive phosphorylation of ATM in lymphoblastoid cell lines from patients with ICF syndrome without downstream kinase activity. DNA Repair (Amst.) 5 (2006) 432-443
18. Peterson C.L., and Cote J. Cellular machineries for chromosomal DNA repair. Genes Dev. 18 (2004) 602-616
19. Rubbi C.P., and Milner J. p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage. EMBO J. 22 (2003) 975-986
20. Carrier F., Georgel P.T., Pourquier P., Blake M., Kontny H.U., Antinore M.J., Gariboldi M., Myers T.G., Weinstein J.N., Pommier Y., and Fornace Jr. A.J. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Mol. Cell. Biol. 19 (1999) 1673-1685
21. Hilfiker A., Hilfiker-Kleiner D., Pannuti A., and Lucchesi J.C. mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila. EMBO J. 16 (1997) 2054-2060
22. Gupta A., Sharma G.G., Young C.S., Agarwal M., Smith E.R., Paull T.T., Lucchesi J.C., Khanna K.K., Ludwig T., and Pandita T.K. Involvement of human MOF in ATM function. Mol. Cell. Biol. 25 (2005) 5292-5305
23. West M.H., and Bonner W.M. Histone 2A, a heteromorphous family of eight protein species. Biochemistry 19 (1980) 3238-3245
24. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., and Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine-139. J. Biol. Chem. 273 (1998) 5858-5868
25. Rogakou E.P., Boon C., Redon C., and Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146 (1999) 905-916
26. Ward I.M., and Chen J.J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276 (2001) 47759-47762
27. Furuta T., Takemura H., Liao Z.Y., Aune G.J., Redon C., Sedelnikova O.A., Pilch D.R., Rogakou E.P., Celeste A., Chen H.T., Nussenzweig A., Aladjem M.I., Bonner W.M., and Pommier Y. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J. Biol. Chem. 278 (2003) 20303-20312
28. Lu C., Zhu F., Cho Y.Y., Tang F., Zykova T., Ma W.Y., Bode A.M., and Dong Z. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol. Cell 23 (2006) 121-132
29. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003) 194-198
30. Takai H., Smogorzewska A., and de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13 (2003) 1549-1556
31. Celeste A., Fernandez-Capetillo O., Kruhlak M.J., Pilch D.R., Staudt D.W., Lee A., Bonner R.F., Bonner W.M., and Nussenzweig A. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat. Cell Biol. 5 (2003) 675-679
32. Strom L., Lindroos H.B., Shirahige K., and Sjogren C. Postreplicative recruitment of cohesin to double-strand breaks is required for DNA repair. Mol. Cell 16 (2004) 1003-1015
33. Unal E., Arbel-Eden A., Sattler U., Shroff R., Lichten M., Haber J.E., and Koshland D. DNA damage response pathway uses histone modification to assemble a double-strand break-specific cohesin domain. Mol. Cell 16 (2004) 991-1002
34. Xie A., Puget N., Shim I., Odate S., Jarzyna I., Bassing C.H., Alt F.W., and Scully R. Control of sister chromatid recombination by histone H2AX. Mol. Cell 16 (2004) 1017-1025
35. Chowdhury D., Keogh M.C., Ishii H., Peterson C.L., Buratowski S., and Lieberman J. Gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol. Cell 20 (2005) 801-809
36. Bouquet F., Muller C., and Salles B. The loss of gammaH2AX signal is a marker of DNA double strand breaks repair only at low levels of DNA damage. Cell Cycle 5 (2006) 1116-1122
37. Kusch T., Florens L., Macdonald W.H., Swanson S.K., Glaser R.L., Yates III J.R., Abmayr S.M., Washburn M.P., and Workman J.L. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 306 (2004) 2084-2087
38. Krogan N.J., Lam M.H., Fillingham J., Keogh M.C., Gebbia M., Li J., Datta N., Cagney G., Buratowski S., Emili A., and Greenblatt J.F. Proteasome involvement in the repair of DNA double-strand breaks. Mol. Cell 16 (2004) 1027-1034
39. Keogh M.C., Kim J.A., Downey M., Fillingham J., Chowdhury D., Harrison J.C., Onishi M., Datta N., Galicia S., Emili A., Lieberman J., Shen X., Buratowski S., Haber J.E., Durocher D., Greenblatt J.F., and Krogan N.J. A phosphatase complex that dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery. Nature 439 (2006) 497-501
40. Stewart G.S., Maser R.S., Stankovic T., Bressan D.A., Kaplan M.I., Jaspers N.G.J., Raams A., Byrd P.J., Petrini J.H.J., and Taylor A.M.R. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an Ataxia telangiectasia-like disorder. Cell 99 (1999) 577-587
41. Varon R., Vissinga C., Platzer M., Cerosaletti K.M., Chrzanowska K.H., Saar K., Beckmann G., Seemanova E., Cooper P.R., Nowak N.J., Stumm M., Weemaes C.M.R., Gatti R.A., Wilson R.K., Digweed M., Rosenthal A., Sperling K., Concannon P., and Reis A. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93 (1998) 467-476
42. Lim D.S., Kim S.T., Xu B., Maser R.S., Lin J.Y., Petrini J.H.J., and Kastan M.B. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404 (2000) 613-617
43. Hofmann K., and Bucher P. The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors. Trends Biochem. Sci. 20 (1995) 347-349
44. Durocher D., and Jackson S.P. The FHA domain. FEBS Lett. 513 (2002) 58-66
45. Durocher D., Taylor I.A., Sarbassova D., Haire L.F., Westcott S.L., Jackson S.P., Smerdon S.J., and Yaffe M.B. The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms. Mol. Cell 6 (2000) 1169-1182
46. Williams R.S., Bernstein N., Lee M.S., Rakovszky M.L., Cui D., Green R., Weinfeld M., and Glover J.N. Structural basis for phosphorylation-dependent signaling in the DNA-damage response. Biochem. Cell Biol. 83 (2005) 721-727
47. Clapperton J.A., Manke I.A., Lowery D.M., Ho T., Haire L.F., Yaffe M.B., and Smerdon S.J. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Nat. Struct. Mol. Biol. 11 (2004) 512-518
48. Becker E., Meyer V., Madaoui H., and Guerois R. Detection of a tandem BRCT in Nbs1 and Xrs2 with functional implications in the DNA damage response. Bioinformatics 22 (2006) 1289-1292
49. Kobayashi J., Tauchi H., Sakamoto S., Nakamura A., Morishima K., Matsuura S., Kobayashi T., Tamai K., Tanimoto K., and Komatsu K. NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain. Curr. Biol. 12 (2002) 1846-1851
50. Williams B.R., Mirzoeva O.K., Morgan W.F., Lin J., Dunnick W., and Petrini J.H. A murine model of Nijmegen breakage syndrome. Curr. Biol. 12 (2002) 648-653
51. Difilippantonio S., Celeste A., Fernandez-Capetillo O., Chen H.T., Martin B.R.S., Van Laethem F., Yang Y.P., Petukhova G.V., Eckhaus M., Feigenbaum L., Manova K., Kruhlak M., Camerini-Otero R.D., Sharan S., Nussenzweig M., and Nussenzweig A. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat. Cell. Biol. 7 (2005) 675-685
52. Lisby M., Barlow J.H., Burgess R.C., and Rothstein R. Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins. Cell 118 (2004) 699-713
53. Lou Z., Minter-Dykhouse K., Franco S., Gostissa M., Rivera M.A., Celeste A., Manis J.P., van Deursen J., Nussenzweig A., Paull T.T., Alt F.W., and Chen J. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol. Cell 21 (2006) 187-200
54. Lukas C., Melander F., Stucki M., Falck J., Bekker-Jensen S., Goldberg M., Lerenthal Y., Jackson S.P., Bartek J., and Lukas J. Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention. EMBO J. 23 (2004) 2674-2683
55. Lee J.H., and Paull T.T. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304 (2004) 93-96
56. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., and Weitzman M.D. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22 (2003) 6610-6620
57. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., and Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22 (2003) 5612-5621
58. Falck J., Coates J., and Jackson S.P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434 (2005) 605-611
59. You Z., Chahwan C., Bailis J., Hunter T., and Russell P. ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1. Mol. Cell. Biol. 25 (2005) 5363-5379
60. Jazayeri A., Falck J., Lukas C., Bartek J., Smith G.C., Lukas J., and Jackson S.P. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8 (2006) 37-45
61. Bekker-Jensen S., Lukas C., Melander F., Bartek J., and Lukas J. Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1. J. Cell Biol. 170 (2005) 201-211
62. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., and Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10 (2000) 886-895
63. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., and Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421 (2003) 961-966
64. Rappold I., Iwabuchi K., Date T., and Chen J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J. Cell. Biol. 153 (2001) 613-620
65. Xia Z., Morales J.C., Dunphy W.G., and Carpenter P.B. Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1. J. Biol. Chem. 276 (2001) 2708-2718
66. Ward I.M., Minn K., Jorda K.G., and Chen J. Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J. Biol. Chem. 278 (2003) 19579-19582
67. Schultz L.B., Chehab N.H., Malikzay A., and Halazonetis T.D. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 151 (2000) 1381-1390
68. Mochan T.A., Venere M., DiTullio Jr. R.A., and Halazonetis T.D. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res. 63 (2003) 8586-8591
69. Huyen Y., Zgheib O., Ditullio Jr. R.A., Gorgoulis V.G., Zacharatos P., Petty T.J., Sheston E.A., Mellert H.S., Stavridi E.S., and Halazonetis T.D. Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432 (2004) 406-411
70. Bekker-Jensen S., Lukas C., Kitagawa R., Melander F., Kastan M.B., Bartek J., and Lukas J. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J. Cell Biol. 173 (2006) 195-206
71. Nevanlinna H., and Bartek J. The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25 (2006) 5912-5919
72. Falck J., Mailand N., Syljuasen R.G., Bartek J., and Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410 (2001) 842-847
73. Li J., Williams B.L., Haire L.F., Goldberg M., Wilker E., Durocher D., Yaffe M.B., Jackson S.P., and Smerdon S.J. Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2. Mol. Cell 9 (2002) 1045-1054
74. Bell D.W., Varley J.M., Szydlo T.E., Kang D.H., Wahrer D.C., Shannon K.E., Lubratovich M., Verselis S.J., Isselbacher K.J., Fraumeni J.F., Birch J.M., Li F.P., Garber J.E., and Haber D.A. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286 (1999) 2528-2531
75. Wu X., Webster S.R., and Chen J. Characterization of tumor-associated Chk2 mutations. J. Biol. Chem. 276 (2001) 2971-2974
76. Falck J., Lukas C., Protopopova M., Lukas J., Selivanova G., and Bartek J. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway. Oncogene 20 (2001) 5503-5510
77. Ahn J.Y., Li X., Davis H.L., and Canman C.E. Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain. J. Biol. Chem. 277 (2002) 19389-19395
78. Ahn J., and Prives C. Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylation. J. Biol. Chem. 277 (2002) 48418-48426
79. Matsuoka S., Huang M.X., and Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282 (1998) 1893-1897
80. Lukas C., Falck J., Bartkova J., Bartek J., and Lukas J. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat. Cell Biol. 5 (2003) 255-260
81. Ahn J., Urist M., and Prives C. The Chk2 protein kinase. DNA Repair (Amst.) 3 (2004) 1039-1047
82. Brown E.J., and Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14 (2000) 397-402
83. de Klein A., Muijtjens M., van Os R., Verhoeven Y., Smit B., Carr A.M., Lehmann A.R., and Hoeijmakers J.H. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol. 10 (2000) 479-482
84. O'Driscoll M., Ruiz-Perez V.L., Woods C.G., Jeggo P.A., and Goodship J.A. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33 (2003) 497-501
85. Walter J., and Newport J. Initiation of eukaryotic DNA replication: origin unwinding and sequential chromatin association of Cdc45, RPA, and DNA polymerase alpha. Mol. Cell 5 (2000) 617-627
86. Zou L., and Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300 (2003) 1542-1548
87. Michael W.M., Ott R., Fanning E., and Newport J. Activation of the DNA replication checkpoint through RNA synthesis by primase. Science 289 (2000) 2133-2137
88. Liu Q., Guntuku S., Cui X.S., Matsuoka S., Cortez D., Tamai K., Luo G., Carattini-Rivera S., DeMayo F., Bradley A., Donehower L.A., and Elledge S.J. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14 (2000) 1448-1459
89. Takai H., Tominaga K., Motoyama N., Minamishima Y.A., Nagahama H., Tsukiyama T., Ikeda K., Nakayama K., Nakanishi M., and Nakayama K. Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev. 14 (2000) 1439-1447
90. Walworth N., Davey S., and Beach D. Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2. Nature 363 (1993) 368-371
91. Jiang K., Pereira E., Maxfield M., Russell B., Goudelock D.M., and Sanchez Y. Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345. J. Biol. Chem. 278 (2003) 25207-25217
92. Gatei M., Sloper K., Sorensen C., Syljuasen R., Falck J., Hobson K., Savage K., Lukas J., Zhou B.B., Bartek J., and Khanna K.K. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J. Biol. Chem. 278 (2003) 14806-14811
93. Zhao H., Watkins J.L., and Piwnica-Worms H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 14795-14800
94. Chen M.S., Ryan C.E., and Piwnica-Worms H. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol. Cell. Biol. 23 (2003) 7488-7497
95. Sorensen C.S., Syljuasen R.G., Falck J., Schroeder T., Ronnstrand L., Khanna K.K., Zhou B.B., Bartek J., and Lukas J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 3 (2003) 247-258
96. Zhao H., and Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 21 (2001) 4129-4139
97. Chen P., Luo C., Deng Y., Ryan K., Register J., Margosiak S., Tempczyk-Russell A., Nguyen B., Myers P., Lundgren K., Kan C.C., and O'Connor P.M. The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation. Cell 100 (2000) 681-692
98. Oe T., Nakajo N., Katsuragi Y., Okazaki K., and Sagata N. Cytoplasmic occurrence of the Chk1/Cdc25 pathway and regulation of Chk1 in Xenopus oocytes. Dev. Biol. 229 (2001) 250-261
99. Shieh S.Y., Ahn J., Tamai K., Taya Y., and Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14 (2000) 289-300
100. Chehab N.H., Malikzay A., Appel M., and Halazonetis T.D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14 (2000) 278-288
101. Jallepalli P.V., Lengauer C., Vogelstein B., and Bunz F. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J. Biol. Chem. 278 (2003) 20475-20479
102. Ahn J., Urist M., and Prives C. Questioning the role of checkpoint kinase 2 in the p53 DNA damage response. J. Biol. Chem. 278 (2003) 20480-20489
103. Bell S.P., and Dutta A. DNA replication in eukaryotic cells. Annu. Rev. Biochem. 71 (2002) 333-374
104. Weiss R.S., Matsuoka S., Elledge S.J., and Leder P. Hus1 acts upstream of chk1 in a mammalian DNA damage response pathway. Curr. Biol. 12 (2002) 73-77
105. Roos-Mattjus P., Hopkins K.M., Oestreich A.J., Vroman B.T., Johnson K.L., Naylor S., Lieberman H.B., and Karnitz L.M. Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling. J. Biol. Chem. 278 (2003) 24428-24437
106. Chini C.C., Wood J., and Chen J. Chk1 is required to maintain claspin stability. Oncogene 25 (2006) 4165-4171
107. Wang X., Zou L., Lu T., Bao S., Hurov K.E., Hittelman W.N., Elledge S.J., and Li L. Rad17 phosphorylation is required for claspin recruitment and Chk1 activation in response to replication stress. Mol. Cell 23 (2006) 331-341
108. Kumagai A., and Dunphy W.G. Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1. Nat. Cell Biol. 5 (2003) 161-165
109. Kumagai A., Lee J., Yoo H.Y., and Dunphy W.G. TopBP1 activates the ATR-ATRIP complex. Cell 124 (2006) 943-955
110. Kumagai A., and Dunphy W.G. How cells activate ATR. Cell Cycle 5 (2006) 1265-1268
111. Lieber M.R., Ma Y., Pannicke U., and Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat. Rev. Mol. Cell. Biol. 4 (2003) 712-720
112. Weterings E., and van Gent D.C. The mechanism of non-homologous end-joining: a synopsis of synapsis. DNA Repair (Amst.) 3 (2004) 1425-1435
113. Ahnesorg P., Smith P., and Jackson S.P. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124 (2006) 301-313
114. Buck D., Malivert L., de Chasseval R., Barraud A., Fondaneche M.C., Sanal O., Plebani A., Stephan J.L., Hufnagel M., le Deist F., Fischer A., Durandy A., de Villartay J.P., and Revy P. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124 (2006) 287-299
115. Jin S.F., and Weaver D.T. Double-strand break repair by Ku70 requires heterodimerization with Ku80 and DNA-binding functions. EMBO J. 16 (1997) 6874-6885
116. Hennequin C., Giocanti N., Averbeck D., and Favaudon V. DNA-dependent protein kinase (DNA-PK), a key enzyme in the re-ligation of double-stranded DNA breaks. Cancer Radiother. 3 (1999) 289-295
117. Collis S.J., DeWeese T.L., Jeggo P.A., and Parker A.R. The life and death of DNA-PK. Oncogene 24 (2005) 949-961
118. Carter T., Vancurova I., Sun I., Lou W., and DeLeon S. A DNA-activated protein kinase from HeLa cell nuclei. Mol. Cell. Biol. 10 (1990) 6460-6471
119. Merkle D., Douglas P., Moorhead G.B., Leonenko Z., Yu Y., Cramb D., Bazett-Jones D.P., and Lees-Miller S.P. The DNA-dependent protein kinase interacts with DNA to form a protein-DNA complex that is disrupted by phosphorylation. Biochemistry 41 (2002) 12706-12714
120. Reddy Y.V., Ding Q., Lees-Miller S.P., Meek K., and Ramsden D.A. Non-homologous end joining requires that the DNA-PK complex undergo an autophosphorylation-dependent rearrangement at DNA ends. J. Biol. Chem. 279 (2004) 39408-39413
121. Ding Q., Reddy Y.V., Wang W., Woods T., Douglas P., Ramsden D.A., Lees-Miller S.P., and Meek K. Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol. Cell. Biol. 23 (2003) 5836-5848
122. Soubeyrand S., Pope L., Pakuts B., and Hache R.J. Threonines 2638/2647 in DNA-PK are essential for cellular resistance to ionizing radiation. Cancer Res. 63 (2003) 1198-1201
123. Douglas P., Moorhead G.B., Ye R., and Lees-Miller S.P. Protein phosphatases regulate DNA-dependent protein kinase activity. J. Biol. Chem. 276 (2001) 18992-18998
124. Douglas P., Sapkota G.P., Morrice N., Yu Y., Goodarzi A.A., Merkle D., Meek K., Alessi D.R., and Lees-Miller S.P. Identification of in vitro and in vivo phosphorylation sites in the catalytic subunit of the DNA-dependent protein kinase. Biochem. J. 368 (2002) 243-251
125. Block W.D., Yu Y., Merkle D., Gifford J.L., Ding Q., Meek K., and Lees-Miller S.P. Autophosphorylation-dependent remodeling of the DNA-dependent protein kinase catalytic subunit regulates ligation of DNA ends. Nucleic Acids Res. 32 (2004) 4351-4357
126. Chan D.W., Chen B.P., Prithivirajsingh S., Kurimasa A., Story M.D., Qin J., and Chen D.J. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev. 16 (2002) 2333-2338
127. Convery E., Shin E.K., Ding Q., Wang W., Douglas P., Davis L.S., Nickoloff J.A., Lees-Miller S.P., and Meek K. Inhibition of homologous recombination by variants of the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs). Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1345-1350
128. Cui X., Yu Y., Gupta S., Cho Y.M., Lees-Miller S.P., and Meek K. Autophosphorylation of DNA-dependent protein kinase regulates DNA end processing and may also alter double-strand break repair pathway choice. Mol. Cell. Biol. 25 (2005) 10842-10852
129. Allen C., Halbrook J., and Nickoloff J.A. Interactive competition between homologous recombination and non-homologous end joining. Mol. Cancer Res. 1 (2003) 913-920
130. Chan D.W., and Lees-Miller S.P. The DNA-dependent protein kinase is inactivated by autophosphorylation of the catalytic subunit. J. Biol. Chem. 271 (1996) 8936-8941
131. Wechsler T., Chen B.P., Harper R., Morotomi-Yano K., Huang B.C., Meek K., Cleaver J.E., Chen D.J., and Wabl M. DNA-PKcs function regulated specifically by protein phosphatase 5. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1247-1252
132. Jiang X., Sun Y., Chen S., Roy K., and Price B.D. The FATC domains of PIKK proteins are functionally equivalent and participate in the Tip60-dependent activation of DNA-PKcs and ATM. J. Biol. Chem. 281 (2006) 15741-15746
133. Chan D.W., Ye R.Q., Veillette C.J., and Lees-Miller S.P. DNA-dependent protein kinase phosphorylation sites in Ku70/80 heterodimer. Biochemistry 38 (1999) 1819-1828
134. Douglas P., Gupta S., Morrice N., Meek K., and Lees-Miller S.P. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining. DNA Repair (Amst.) 4 (2005) 1006-1018
135. Lee K.J., Jovanovic M., Udayakumar D., Bladen C.L., and Dynan W.S. Identification of DNA-PKcs phosphorylation sites in XRCC4 and effects of mutations at these sites on DNA end joining in a cell-free system. DNA Repair (Amst.) 3 (2004) 267-276
136. Wang Y.G., Nnakwe C., Lane W.S., Modesti M., and Frank K.M. Phosphorylation and regulation of DNA ligase IV stability by DNA-dependent protein kinase. J. Biol. Chem. 279 (2004) 37282-37290
137. Drouet J., Delteil C., Lefrancois J., Concannon P., Salles B., and Calsou P. DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell in response to DNA double strand breaks. J. Biol. Chem. 280 (2005) 7060-7069
138. Riballo E., Kuhne M., Rief N., Doherty A., Smith G.C., Recio M.J., Reis C., Dahm K., Fricke A., Krempler A., Parker A.R., Jackson S.P., Gennery A., Jeggo P.A., and Lobrich M. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol. Cell 16 (2004) 715-724
139. Wang J., Pluth J.M., Cooper P.K., Cowan M.J., Chen D.J., and Yannone S.M. Artemis deficiency confers a DNA double-strand break repair defect and Artemis phosphorylation status is altered by DNA damage and cell cycle progression. DNA Repair (Amst.) 4 (2005) 556-570
140. Niewolik D., Pannicke U., Lu H., Ma Y., Wang L.C., Kulesza P., Zandi E., Lieber M.R., and Schwarz K. DNA-PKcs dependence of Artemis endonucleolytic activity, differences between hairpins and 5′ or 3′ overhangs. J. Biol. Chem. 281 (2006) 33900-33909
141. Ma Y., Pannicke U., Lu H., Niewolik D., Schwarz K., and Lieber M.R. The DNA-dependent protein kinase catalytic subunit phosphorylation sites in human Artemis. J. Biol. Chem. 280 (2005) 33839-33846
142. Lundin C., Erixon K., Arnaudeau C., Schultz N., Jenssen D., Meuth M., and Helleday T. Different roles for nonhomologous end joining and homologous recombination following replication arrest in mammalian cells. Mol. Cell. Biol. 22 (2002) 5869-5878
143. Masson J.-Y., Tarsounas M.C., Stasiak A.Z., Stasiak A., Shah R., McIlwraith M.J., Benson F.E., and West S.C. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 15 (2001) 3296-3307
144. Liu Y., Masson J.Y., Shah R., O'Regan P., and West S.C. RAD51C is required for Holliday junction processing in mammalian cells. Science 303 (2004) 243-246
145. Antunez de Mayolo A., Lisby M., Erdeniz N., Thybo T., Mortensen U.H., and Rothstein R. Multiple start codons and phosphorylation result in discrete Rad52 protein species. Nucleic Acids Res. 34 (2006) 2587-2597
146. Kitao H., and Yuan Z.M. Regulation of ionizing radiation-induced Rad52 nuclear foci formation by c-Abl-mediated phosphorylation. J. Biol. Chem. 277 (2002) 48944-48948
147. Sacher M., Pfander B., Hoege C., and Jentsch S. Control of Rad52 recombination activity by double-strand break-induced SUMO modification. Nat. Cell Biol. 8 (2006) 1284-1290
148. Deng C.X., and Wang R.H. Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum. Mol. Genet. 12 Spec. No. 1 (2003) R113-R123
149. Deng C.X., and Brodie S.G. Roles of BRCA1 and its interacting proteins. Bioessays 22 (2000) 728-737
150. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., and Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14 (2000) 927-939
151. Anderson S.E., Schlegel B.P., Nakajima T., Wolpin E.S., and Parvin J.D. Brca1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase a. Nat. Genet. 19 (1998) 254-256
152. Schlegel B.P., Green V.J., Ladias J.A.A., and Parvin J.D. BRCA1 interaction with RNA polymerase II reveals a role for hRPB2 and hRPB10 alpha in activated transcription. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3148-3153
153. Moisan A., and Gaudreau L. The BRCA1 COOH-terminal region acts as an RNA polymerase II carboxyl-terminal domain kinase inhibitor that modulates p21WAF1/CIP1 expression. J. Biol. Chem. 281 (2006) 21119-21130
154. Kitagawa R., and Kastan M.B. The ATM-dependent DNA damage signaling pathway. Cold Spring Harb. Symp. Quant. Biol. 70 (2005) 99-109
155. Cortez D., Wang Y., Qin J., and Elledge S.J. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks. Science 286 (1999) 1162-1166
156. Gatei M., Scott S.P., Filippovitch I., Soronika N., Lavin M.F., Weber B., and Khanna K.K. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res. 60 (2000) 3299-3304
157. Tibbetts R.S., Cortez D., Brumbaugh K.M., Scully R., Livingston D., Elledge S.J., and Abraham R.T. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14 (2000) 2989-3002
158. Lee J.S., Collins K.M., Brown A.L., Lee C.H., and Chung J.H. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404 (2000) 201-204
159. Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., and Brody L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30 (2002) 285-289
160. Xu B., Kim S.T., and Kastan M.B. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21 (2001) 3445-3450
161. Xu B., Kim S.T., Lim D.S., and Kastan M.B. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol. Cell. Biol. 22 (2002) 1049-1059
162. Zhang J., Willers H., Feng Z., Ghosh J.C., Kim S., Weaver D.T., Chung J.H., Powell S.N., and Xia F. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol. Cell. Biol. 24 (2004) 708-718
163. Zhuang J., Zhang J., Willers H., Wang H., Chung J.H., van Gent D.C., Hallahan D.E., Powell S.N., and Xia F. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining. Cancer Res. 66 (2006) 1401-1408
164. Baskaran R., Wood L.D., Whitaker L.L., Canman C.E., Morgan S.E., Xu Y., Barlow C., Baltimore D., Wynshaw-Boris A., Kastan M.B., and Wang J.Y.J. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387 (1997) 516-519
165. Foray N., Marot D., Randrianarison V., Venezia N.D., Picard D., Perricaudet M., Favaudon V., and Jeggo P. Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation. Mol. Cell. Biol. 22 (2002) 4020-4032
166. Esashi F., Christ N., Gannon J., Liu Y., Hunt T., Jasin M., and West S.C. CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434 (2005) 598-604
167. Lee M., Daniels M.J., and Venkitaraman A.R. Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression. Oncogene 23 (2004) 865-872
168. Sorensen C.S., Hansen L.T., Dziegielewski J., Syljuasen R.G., Lundin C., Bartek J., and Helleday T. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat. Cell Biol. 7 (2005) 195-201
169. Busby E.C., Leistritz D.F., Abraham R.T., Karnitz L.M., and Sarkaria J.N. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1. Cancer Res. 60 (2000) 2108-2112
170. Chen G., Yuan S.S.Y., Liu W., Xu Y., Trujillo K., Song B., Cong F., Goff S.P., Wu Y., Arlinghaus R., Baltimore D., Gasser P.J., Park M.S., Sung P., and Lee E.Y.H.P. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATP and c-Abl. J. Biol. Chem. 274 (1999) 12748-12752
171. Yuan S.S., Chang H.L., and Lee E.Y. Ionizing radiation-induced Rad51 nuclear focus formation is cell cycle-regulated and defective in both ATM(-/-) and c-Abl(-/-) cells. Mutat. Res. 525 (2003) 85-92
172. Conilleau S., Takizawa Y., Tachiwana H., Fleury F., Kurumizaka H., and Takahashi M. Location of tyrosine 315, a target for phosphorylation by cAbl tyrosine kinase, at the edge of the subunit-subunit interface of the human Rad51 filament. J. Mol. Biol. 339 (2004) 797-804
173. Boisvert F.M., Cote J., Boulanger M.C., and Richard S. A proteomic analysis of arginine-methylated protein complexes. Mol. Cell. Proteomics 2 (2003) 1319-1330
174. Bedford M.T., and Richard S. Arginine methylation an emerging regulator of protein function. Mol. Cell 18 (2005) 263-272
175. Gary J.D., and Clarke S. RNA and protein interactions modulated by protein arginine methylation. Prog. Nucleic Acid Res. Mol. Biol. 61 (1998) 65-131
176. Boisvert F.M., Dery U., Masson J.Y., and Richard S. Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control. Genes Dev. 19 (2005) 671-676
177. Boisvert F.M., Rhie A., Richard S., and Doherty A.J. The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity. Cell Cycle 4 (2005)
178. Adams M.M., Wang B., Xia Z., Morales J.C., Lu X., Donehower L.A., Bochar D.A., Elledge S.J., and Carpenter P.B. 53BP1 oligomerization is independent of its methylation by PRMT1. Cell Cycle 4 (2005)
179. Cuthbert G.L., Daujat S., Snowden A.W., Erdjument-Bromage H., Hagiwara T., Yamada M., Schneider R., Gregory P.D., Tempst P., Bannister A.J., and Kouzarides T. Histone deimination antagonizes arginine methylation. Cell 118 (2004) 545-553
180. Wang Y., Wysocka J., Sayegh J., Lee Y.H., Perlin J.R., Leonelli L., Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G., Clarke S., Stallcup M.R., Allis C.D., and Coonrod S.A. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306 (2004) 279-283
181. Jeffers J.R., Parganas E., Lee Y., Yang C., Wang J., Brennan J., MacLean K.H., Han J., Chittenden T., Ihle J.N., McKinnon P.J., Cleveland J.L., and Zambetti G.P. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4 (2003) 321-328
182. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., Adams J.M., and Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302 (2003) 1036-1038